| Combinatorial cancer immunotherapy |
2022-9-16 |
2022-12-06 |
|
| Combinatorial cancer immunotherapy |
2022-6-23 |
2022-12-01 |
|
| Armed chimeric receptors and methods of use thereof |
2022-6-16 |
2022-12-22 |
|
| Method and compositions for regulated armoring of cells |
2022-6-10 |
2023-1-12 |
|
| Chimeric receptors and methods of use thereof |
2022-5-06 |
2022-12-08 |
|
| Chimeric antigen receptors and methods of use |
2022-5-06 |
2022-11-10 |
|
| Drug-regulatable transcription factors |
2022-4-19 |
2022-10-27 |
|
| Ert2 mutants and uses thereof |
2022-4-06 |
2022-10-13 |
|
| Ert2 mutants and uses thereof |
2022-4-06 |
2022-10-13 |
|
| Drug-regulatable transcriptional repressors |
2022-4-06 |
2022-10-13 |
|
| Secretable payload regulation |
2022-1-14 |
2022-7-21 |
|
| Chimeric receptors and methods of use thereof |
2021-11-24 |
2022-10-01 |
|
| Inducible cell death systems |
2021-11-22 |
2022-5-27 |
|
| Protein payload release |
2021-11-04 |
2022-5-12 |
|
| Chimeric receptors and methods of use thereof |
2021-10-19 |
2021-12-01 |
|
| Chimeric receptors and methods of use thereof |
2021-10-18 |
2022-6-16 |
|
| Chimeric receptors and methods of use thereof |
2021-10-15 |
2023-4-06 |
|
| Combinatorial cancer immunotherapy |
2021-3-31 |
2021-7-29 |
|
| Inhibitory chimeric receptor architectures |
2021-2-19 |
2022-12-28 |
|
| Inhibitory chimeric receptor architectures |
2021-2-19 |
2022-9-22 |
|
| Chimeric receptor sensors |
2020-10-30 |
2022-12-15 |
|
| Combinatorial cancer immunotherapy |
2020-8-28 |
2022-12-01 |
|
| Chimeric inhibitory receptors |
2020-8-20 |
2022-6-03 |
|
| Fusion constructs for controlling protein function |
2020-1-24 |
2021-12-01 |
|
| Engineered immune cells and methods of use |
2019-5-17 |
2019-11-21 |
|
| Inducible Cell Receptors for Cell-Based Therapeutics |
2018-12-11 |
2021-6-24 |
|
| Immunomodulating cell circuits |
2018-3-16 |
2018-9-20 |
|
| Genetic erasers |
2017-7-26 |
2019-2-07 |
|
| Récepteurs chimériques et procédés d'utilisation de ces derniers |
2021-10-15 |
2023-4-06 |
|